Guidelines for the management of chronic kidney disease in HIV-infected patients: recommendations of the HIV Medicine Association of the Infectious Diseases Society of America.
Gupta
Samir K
SK
Division of Infectious Diseases, Department of Medicine, Indiana University School of Medicine, Indianapolis, IN, USA. sgupta1@iupui.edu
Eustace
Joseph A
JA
Winston
Jonathan A
JA
Boydstun
Ivy I
II
Ahuja
Tejinder S
TS
Rodriguez
Rudolph A
RA
Tashima
Karen T
KT
Roland
Michelle
M
Franceschini
Nora
N
Palella
Frank J
FJ
Lennox
Jeffrey L
JL
Klotman
Paul E
PE
Nachman
Sharon A
SA
Hall
Stephen D
SD
Szczech
Lynda A
LA
D000305:Adrenal Cortex Hormones / Q000627:therapeutic use; D000328:Adult; D000375:Aging; D000806:Angiotensin-Converting Enzyme Inhibitors / Q000627:therapeutic use; D019380:Anti-HIV Agents / Q000009:adverse effects / Q000627:therapeutic use; D023241:Antiretroviral Therapy, Highly Active / Q000009:adverse effects; D002648:Child; D004305:Dose-Response Relationship, Drug; D005260:Female; D015658:HIV Infections / Q000150:complications* / Q000188:drug therapy; D006801:Humans; D015994:Incidence; D007676:Kidney Failure, Chronic / Q000175:diagnosis / Q000453:epidemiology / Q000209:etiology* / Q000628:therapy*; D008297:Male; D015995:Prevalence; D012307:Risk Factors
D000305:Adrenal Cortex Hormones; D000806:Angiotensin-Converting Enzyme Inhibitors; D019380:Anti-HIV Agents